| Cell line name |
X50-7 |
|---|
| Accession |
CVCL_8277 |
|---|
| Resource Identification Initiative |
To cite this cell line use: X50-7 (RRID:CVCL_8277) |
|---|
| Comments |
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Children:
|
|---|
| Age at sampling |
<1D |
|---|
| Category |
Transformed cell line |
|---|
| Publications | PubMed=218224; DOI=10.1073/pnas.76.2.949; PMCID=PMC383102
George Miller, Pauline M.E. Wertheim-van Dillen, Gareth Wilson, J. Robinson, Jan L.M.C. Geelen, Jan van der Noordaa, Alex Jan van der Eb;
Transfection of human lymphoblastoid cells with herpes simplex viral DNA.
Proc. Natl. Acad. Sci. U.S.A. 76:949-953(1979) PubMed=223286; DOI=10.1016/0042-6822(79)90490-2
Gareth Wilson, George Miller;
Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
Virology 95:351-358(1979) PubMed=3033285; DOI=10.1128/JVI.61.5.1602-1608.1987; PMCID=PMC254141
Karen Elizabeth Dahl, Kelsey Catherine Martin, George Miller;
Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus.
J. Virol. 61:1602-1608(1987) Patent=US5178999
George Miller, Karen Elizabeth Dahl;
Epstein-Barr virus transformed cell lines superinfected with a second virus.
Patent number US5178999, 12-Jan-1993 |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54994648
|
|---|
| Entry history |
|---|
| Entry creation | 04-Apr-2012 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 11 |
|---|
